Antitumoral activity of 13-demethyl or 13-substituted analogues of all-trans retinoic acid and 9-cis retinoic acid in the human myeloid leukemia cell line HL-60

Biological and Pharmaceutical Bulletin

Volumn 29, Issue 9, 2006, Pages 1803-1809

  Mizuguchi, Yukari ^a   Wada, Akimori ^a   Nakagawa, Kimie ^a   Ito, Masayoshi ^a   Okano, Toshio ^a  

^a KOBE PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

9 cis retinoic acid (9CRA); All trans retinoic acid (ATRA); Retinoic acid receptor (RAR); Retinoic acid response element (RARE); Retinoid X receptor (RXR); Retinoid X response element (RXRE)

Indexed keywords

ALITRETINOIN; DNA FRAGMENT; LUCIFERASE; MEMBRANE ANTIGEN; RETINOIC ACID;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL; CELL CYCLE PHASE; CELL DIFFERENTIATION; CELL PROLIFERATION; DRUG ACTIVITY; DRUG MECHANISM; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HUMAN CELL; MYELOID LEUKEMIA;

ANTIGENS, CD11B; ANTINEOPLASTIC AGENTS; CELL CYCLE; DOSE-RESPONSE RELATIONSHIP, DRUG; HL-60 CELLS; HUMANS; RECEPTORS, RETINOIC ACID; RETINOID X RECEPTORS; TRETINOIN;

EID: 33748358908     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.29.1803     Document Type: Article

References (17)

1. Chomienne C., Balitrand N., Ballerini P., Castaigne S., Degos L., J. Clin. Invest., 88, 2150-2154 (1991).
2. Warrell R. P., Annu. Rev. Med., 47, 555-565 (1996).
3. Kliewer S. A., Umesono K., Mangelsdorf D. J., Evans R. M., Nature (London), 355, 446-452 (1992).
4. Giguere V., Ong E. S., Segui P., Evans R. M., Nature (London), 330, 624-629 (1987).
5. Martin S. J., Bradley J. G., Cotter T. G., Clin. Exp. Immunol., 79, 448-453 (1990).
6. Wada A., Fujioka N., Tanaka Y., Ito M., J. Org. Chem., 8, 2438-2443 (2000).
7. Wada A., Fukunaga K., Ito M., Mizuguchi Y., Nakagawa K., Okano T., Bioorg. Med. Chem., 12, 3931-3942 (2004).
8. de The H., Vivanco-Ruiz M. M., Tiollais P., Stunnenberg H., Dejean A., Nature (London), 343, 177-180 (1990).
9. Mangelsdorf D. J., Umesono K., Kliewer S. A., Borgmeyer U., Ong E. S., Evans R. M., Cell, 66, 555-561 (1991).
10. Breitman T. R., Selonick S. E., Collins S. J., Proc. Natl. Acad. Sci. U.S.A., 77, 2936-2940 (1980).
11. Collins S. J., Gallo R. C., Gallagher R. E., Nature (London), 270, 347-349 (1977).
12. Lee K. H., Chang M. Y., Ahn J. I., Yu D. J., Jung S. S., Choi J. h., Noh Y. H., Lee Y. S., Ahn M. J., Biochem. Biophys. Res. Commun., 296, 1125-1133 (2002).
13. Eremin S. V., Mitsner B. I., Danshina S. V., Khitrina L. V., Bioorg. Khim., 14, 421-423 (1988).
14. Danshina S. V., Alexander L. D., Eremin S. V., Arch. Biochem. Biophys., 279, 225-231 (1990).
15. Nagy L., Thomazy V. A., Shipley G. L., Fesus L., Mol. Cell Biol., 15, 3540-3551 (1995).
16. Delescluse C., Cavey M. T., Martin B., Bernard B. A., Reichert U., Maignan J., Darmon M., Shroot B., Mol. Pharmacol., 40, 556-562 (1991).
17. Umemiya H., Kagechika H., Fukasawa H., Kawachi E., Ebisawa M., Hashimoto Y., Eisenmann G., Erb C., Porno A., Chambon P., Gronemeyer H., Shudo K., Biochem. Biophys. Res. Commun., 233, 121-125 (1997).